Saillant Therapeutics BV
- Biotech or pharma, therapeutic R&D
Small molecule in the GLP tox phase against a new mechanism inducing tissue regeneration in heart failure (HFrEF and HFpEF), kidney failure, neurodegenerative diseases, fibrosis, diabetes.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}